...
首页> 外文期刊>Journal of Thoracic Disease >Peroxisome proliferator-activated receptor-γ in induced sputum is correlated with MMP-9/TIMP-1 imbalance and formation of emphysema in COPD patients
【24h】

Peroxisome proliferator-activated receptor-γ in induced sputum is correlated with MMP-9/TIMP-1 imbalance and formation of emphysema in COPD patients

机译:慢性阻塞性肺病患者痰中过氧化物酶体增殖物激活受体-γ与MMP-9 / TIMP-1失衡及肺气肿形成有关

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: The development of chronic obstructive pulmonary disease (COPD) is modulated by the symmetry of matrix metalloproteinases (MMPs) and the counter-acting tissue inhibitors of metalloproteinases (TIMPs). We investigated the interaction between peroxisome proliferator-activated receptor gamma (PPARγ) expression and the imbalance of MMP-9/TIMP-1 in the induced sputum of stable COPD patients. Methods: Sixty-six stable COPD patients were enrolled and the induced sputum samples were gathered. The correlation between PPARγ and other index, including MMP-9, TIMP-1, pulmonary function and the index of emphysema—the percentage of low attenuation area (LAA%), was analyzed. Results: PPARγ and TIMP-1 concentrations were decreased and the concentration of MMP-9 and the ratio of MMP9/TIMP1 were enhanced in the induced sputum of COPD patients, compared to the healthy controls. Among COPD patients, those with worse lung function or patients with emphysema exhibited increased MMP-9 expression with decreased TIMP-1 and PPARγ expression. Besides, the concentration of PPARγ of the induced sputum was correlated with the forced expiratory volume in one second percentage (FEV1%) positively and the expression of TIMP-1; while it was negatively correlated with the residual volume (RV), RV/total lung capacity (TLC), LAA%, and MMP-9 expression. Conclusions: Our findings reveal the protective role of PPARγ in the maintenance of the dynamic balance of MMP-9/TIMP-1 in COPD, thus providing evidence on which to base the potential COPD treatment.
机译:背景:慢性阻塞性肺疾病(COPD)的发展受到基质金属蛋白酶(MMPs)和金属蛋白酶(TIMPs)的反作用组织抑制剂的对称性的调节。我们研究了过氧化物酶体增殖物激活受体γ(PPARγ)表达与稳定COPD患者痰中MMP-9 / TIMP-1失衡之间的相互作用。方法:纳入66例稳定的COPD患者并收集诱导痰标本。分析了PPARγ与其他指标之间的相关性,包括MMP-9,TIMP-1,肺功能和肺气肿指标(低衰减面积百分比(LAA%))。结果:与健康对照组相比,COPD患者诱导痰中PPARγ和TIMP-1浓度降低,MMP-9浓度和MMP9 / TIMP1比值升高。在COPD患者中,肺功能较差或肺气肿患者表现出MMP-9表达升高而TIMP-1和PPARγ表达降低。此外,诱导痰中PPARγ的浓度与强制呼气量(FEV1%)和TIMP-1的表达呈正相关。而与残留体积(RV),RV /总肺活量(TLC),LAA%和MMP-9表达呈负相关。结论:我们的发现揭示了PPARγ在维持COPD中MMP-9 / TIMP-1动态平衡中的保护作用,从而为潜在的COPD治疗奠定了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号